Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,962
Total Claims
$2.3M
Drug Cost
1,521
Beneficiaries
$1,539
Cost/Patient
Risk Score Breakdown 23/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+81%
Opioid rate vs peers
63.0% vs 34.8% avg
+265%
Cost per patient vs peers
$1,539 vs $422 avg
+178%
Brand preference vs peers
13.1% vs 4.7% avg
Opioid Prescribing
63.0%
Opioid Rate
10,049
Opioid Claims
$1.7M
Opioid Cost
30.1%
Long-Acting Rate
This provider's opioid prescribing rate of 63.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 2,098 claims · $1.3M
Generic: 13,864 claims · $1.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 1,968 | $426K |
| Buprenorphine Hcl | 581 | $420K |
| Buprenorphine | 446 | $156K |
| Oxycodone Hcl | 207 | $132K |
| Oxycodone Myristate | 215 | $127K |
| Oxycodone Hcl/Acetaminophen | 34 | $104K |
| Hydrocodone/Acetaminophen | 2,984 | $94K |
| Methylnaltrexone Bromide | 30 | $69K |
| Buprenorphine Hcl/Naloxone Hcl | 586 | $67K |
| Suvorexant | 114 | $52K |
| Semaglutide | 47 | $48K |
| Buprenorphine Hcl/Naloxone Hcl | 74 | $45K |
| Tirzepatide | 37 | $45K |
| Hydrocodone Bitartrate | 58 | $43K |
| Buprenorphine Hcl | 899 | $37K |
Prescribing Profile
Patient Profile
68
Avg Age
68%
Female
1.87
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data